Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 15, 120-132
Abstract
No abstract availableKeywords
Funding Information
- Prinses Beatrix Spierfonds (W.OR18-18)
- Stichting Spieren voor Spieren
This publication has 58 references indexed in Scilit:
- Age of Onset of RNA Toxicity Influences Phenotypic Severity: Evidence from an Inducible Mouse Model of Myotonic Dystrophy (DM1)PLOS ONE, 2013
- Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 LocusPLOS Genetics, 2012
- Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic moleculesBMC Research Notes, 2011
- Non-ATG–initiated translation directed by microsatellite expansionsProceedings of the National Academy of Sciences, 2010
- Repairing skeletal muscle: regenerative potential of skeletal muscle stem cellsJournal of Clinical Investigation, 2010
- Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle BiopsiesStem Cells, 2007
- CTG Trinucleotide Repeat “Big Jumps”: Large Expansions, Small MicePLOS Genetics, 2007
- Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration abilityJournal of Cell Biology, 2006
- Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic miceNature Genetics, 1997
- Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristicsJournal of Cellular Physiology, 1981